Pfizer (PFE) PT Raised at Jefferies; Stock added to 'Franchise Picks' List

Jefferies analyst Jeffrey Holford raised his price target on Buy-rated Pfizer (NYSE: PFE) to $45.00 (from $42.00) and added the stock to the Jefferies "Franchise Picks" list.

Holford commented, "We expect PFE shares to significantly appreciate over the next 1-2 years based on a better than expected launch of Ibrance, greater appreciation of the durable growth on offer in GEP, further accretive and potentially tax-driven M&A, and the separation of GEP by 2017 at a minimum from the rest of the business."

The firm bumped FY 2015 EPS from $2.07 to $2.08 and FY 2016 EPS from $2.21 to $2.30.

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $34.25 yesterday.

You May Also Be Interested In

• Pfizer Declares Second-Quarter 2024 Dividend
• Central Asia Metals Plc. (CAML:LN) PT Raised to GBP2.15 at Canaccord Genuity
• Stillfront Group AB (SF:SS) (STLFF) PT Lowered to SEK16.25 at Barclays